UK firm develops rapid test for antibiotic susceptibility
This article was originally published in Clinica
UK company Cell Analysis has gained an EU grant worth around £500,000 ($720,000) to help develop a rapid, point-of-care test for assessing antibiotic resistance.
You may also be interested in...
In addition to our daily in-depth coverage of key events relating to the coronavirus pandemic, we’re bringing you a periodic round-up of other significant developments.
Clinical trials in a range of diseases continue to be impacted by concerns about patient safety and health care resources as the COVID-19 pandemic grows.
Stephen Hahn’s low visibility period as the newly installed FDA commissioner comes to an abrupt end. Trump offers generous praise amid COVID-19 response – but how quickly might that change to blame?